Alken Asset Management Ltd

Holdings History for SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0

Investment type: Debt / NOTE 0.625% 4/0

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
31 Dec 2020		-2.7%	$0	0	-750,000	-100%		Q4 2020
30 Sep 2020	2.7%	-0.36%	$693,000	750,000	-100,000	-12%	92.4%	Q3 2020
30 Jun 2020	3%	+2.6%	$751,000	850,000	+750,000	+750%	88.35%	Q2 2020
31 Mar 2020	0.33%	-1.3%	$80,000	100,000	-400,000	-80%	80.0%	Q1 2020
31 Dec 2019	0.78%	+0.78%	$455,000	500,000	+500,000	NEW	91.0%	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.